BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21352258)

  • 1. EGFR in melanoma: clinical significance and potential therapeutic target.
    Boone B; Jacobs K; Ferdinande L; Taildeman J; Lambert J; Peeters M; Bracke M; Pauwels P; Brochez L
    J Cutan Pathol; 2011 Jun; 38(6):492-502. PubMed ID: 21352258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.
    Chung CH; Ely K; McGavran L; Varella-Garcia M; Parker J; Parker N; Jarrett C; Carter J; Murphy BA; Netterville J; Burkey BB; Sinard R; Cmelak A; Levy S; Yarbrough WG; Slebos RJ; Hirsch FR
    J Clin Oncol; 2006 Sep; 24(25):4170-6. PubMed ID: 16943533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGFR gene copy number alterations in primary cutaneous malignant melanomas are associated with poor prognosis.
    Rákosy Z; Vízkeleti L; Ecsedi S; Vokó Z; Bégány A; Barok M; Krekk Z; Gallai M; Szentirmay Z; Adány R; Balázs M
    Int J Cancer; 2007 Oct; 121(8):1729-37. PubMed ID: 17594688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No evidence for ErbB4 gene amplification in malignant melanoma.
    Brockhoff G; Bock M; Gantner S; Hafner C
    Acta Derm Venereol; 2011 Jun; 91(4):488-90. PubMed ID: 21547347
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidermal growth factor receptor in glioblastomas: correlation between gene copy number and protein expression.
    Coulibaly B; Nanni I; Quilichini B; Gaudart J; Metellus P; Fina F; Boucard C; Chinot O; Ouafik L; Figarella-Branger D
    Hum Pathol; 2010 Jun; 41(6):815-23. PubMed ID: 20303140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer.
    Schlomm T; Kirstein P; Iwers L; Daniel B; Steuber T; Walz J; Chun FH; Haese A; Kollermann J; Graefen M; Huland H; Sauter G; Simon R; Erbersdobler A
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6579-84. PubMed ID: 18006757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein overexpression and gene amplification of epidermal growth factor receptor in adult testicular germ cell tumors: potential role in tumor progression.
    Miyai K; Yamamoto S; Asano T; Tamai S; Matsubara O; Tsuda H
    Cancer Sci; 2010 Sep; 101(9):1970-6. PubMed ID: 20608935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical markers and driving mechanisms in melanoma progression: VEGF-C, RhoC, c-Ski/SnoN and EGFR.
    Boone B; Brochez L
    Verh K Acad Geneeskd Belg; 2009; 71(5):251-94. PubMed ID: 20232784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of epidermal growth factor receptor and vascular endothelial growth factor receptor in colorectal adenocarcinoma.
    Kim JY; Bae BN; Kwon JE; Kim HJ; Park K
    APMIS; 2011 Jul; 119(7):449-59. PubMed ID: 21635552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor gene amplification in surgical resected Japanese lung cancer.
    Sasaki H; Shimizu S; Okuda K; Kawano O; Yukiue H; Yano M; Fujii Y
    Lung Cancer; 2009 Jun; 64(3):295-300. PubMed ID: 19058870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of FISH, PCR, and immunohistochemistry in assessing EGFR status in lung adenocarcinoma and correlation with clinicopathologic features.
    El-Zammar OA; Zhang S; Katzenstein AL
    Diagn Mol Pathol; 2009 Sep; 18(3):133-7. PubMed ID: 19704257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas. An immunohistochemical and fluorescence in situ hybridization study.
    Suzuki S; Dobashi Y; Sakurai H; Nishikawa K; Hanawa M; Ooi A
    Cancer; 2005 Mar; 103(6):1265-73. PubMed ID: 15712203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor receptor (EGFR) expression in prostatic adenocarcinoma after hormonal therapy: a fluorescence in situ hybridization and immunohistochemical analysis.
    Marks RA; Zhang S; Montironi R; McCarthy RP; MacLennan GT; Lopez-Beltran A; Jiang Z; Zhou H; Zheng S; Davidson DD; Baldridge LA; Cheng L
    Prostate; 2008 Jun; 68(9):919-23. PubMed ID: 18409189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder.
    Wang X; Zhang S; MacLennan GT; Eble JN; Lopez-Beltran A; Yang XJ; Pan CX; Zhou H; Montironi R; Cheng L
    Clin Cancer Res; 2007 Feb; 13(3):953-7. PubMed ID: 17289890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number.
    Kim MA; Lee HS; Lee HE; Jeon YK; Yang HK; Kim WH
    Histopathology; 2008 May; 52(6):738-46. PubMed ID: 18397279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma.
    Mendrzyk F; Korshunov A; Benner A; Toedt G; Pfister S; Radlwimmer B; Lichter P
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2070-9. PubMed ID: 16609018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and amplification of Her2, EGFR and cyclin D1 in breast cancer: immunohistochemistry and chromogenic in situ hybridization.
    Cho EY; Choi YL; Han JJ; Kim KM; Oh YL
    Pathol Int; 2008 Jan; 58(1):17-25. PubMed ID: 18067636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein expression and gene amplification of epidermal growth factor receptor in thymomas.
    Ionescu DN; Sasatomi E; Cieply K; Nola M; Dacic S
    Cancer; 2005 Feb; 103(3):630-6. PubMed ID: 15630697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homogeneous EGFR amplification defines a subset of aggressive Barrett's adenocarcinomas with poor prognosis.
    Marx AH; Zielinski M; Kowitz CM; Dancau AM; Thieltges S; Simon R; Choschzick M; Yekebas E; Kaifi JT; Mirlacher M; Atanackovic D; Brümmendorf TH; Fiedler W; Bokemeyer C; Izbicki JR; Sauter G
    Histopathology; 2010 Sep; 57(3):418-26. PubMed ID: 20840671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of chromogenic in situ hybridization (CISH) for detection of EGFR amplification in glioblastoma: comparison with fluorescence in situ hybridization (FISH).
    Fischer I; de la Cruz C; Rivera AL; Aldape K
    Diagn Mol Pathol; 2008 Dec; 17(4):227-30. PubMed ID: 18382350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.